Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia

By Thomas Xavier   Dombret Hervé  

Hematology, Vol. 12, Iss. 1, 2007-02 ,pp. : 15-28

Maney Publishing

Access to resources Recommend Favorite

Sustained expression of nucleophosmin (NPM1) mutation at late relapse presenting as isolated myeloid sarcoma in a patient with acute myeloid leukemia

By Scholl Sebastian   Lüftner Joachim   Mügge Lars-Olof   Schmidt Volker   Fricke Hans-Jörg   Höffken Klaus  

Annals of Hematology, Vol. 86, Iss. 10, 2007-10 ,pp. : 763-765

Springer Publishing Company

Access to resources Recommend Favorite

Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage

By Re F.   Arpinati M.   Testoni N.   Ricci P.   Terragna C.   Preda P.   Ruggeri D.   Senese B.   Chirumbolo G.   Martelli V.   Urbini B.   Baccarani M.   Tura S.   Rondelli D.  

Experimental Hematology, Vol. 30, Iss. 2, 2002-02 ,pp. : 126-134

Elsevier

Access to resources Recommend Favorite

Acute myelogenous leukemia—microenvironment interactions: Role of endothelial cells and proteasome inhibition

By Liesveld Jane L.   Rosell Karen E.   Lu Chaohui   Bechelli Jeremy   Phillips II Gordon   Lancet Jeffrey E.   Abboud Camille N.  

Hematology, Vol. 10, Iss. 6, 2005-12 ,pp. : 483-494

Maney Publishing

Access to resources Recommend Favorite

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

By Galm Oliver   Wilop Stefan   Lüders Christian   Jost Edgar   Gehbauer Gerald   Herman James   Osieka Rainhardt  

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite